

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | bile acid and bile salt transport (GO:0015721) | 4.66032563 |
| 2 | DNA deamination (GO:0045006) | 4.62452851 |
| 3 | glycine metabolic process (GO:0006544) | 4.40602775 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.29452498 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.29452498 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.05467791 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.05467791 |
| 8 | folic acid metabolic process (GO:0046655) | 3.97627700 |
| 9 | serine family amino acid catabolic process (GO:0009071) | 3.91464500 |
| 10 | glyoxylate metabolic process (GO:0046487) | 3.87662662 |
| 11 | serine family amino acid biosynthetic process (GO:0009070) | 3.83807815 |
| 12 | purine nucleobase biosynthetic process (GO:0009113) | 3.82730217 |
| 13 | nucleobase biosynthetic process (GO:0046112) | 3.75569521 |
| 14 | cysteine metabolic process (GO:0006534) | 3.74296698 |
| 15 | serine family amino acid metabolic process (GO:0009069) | 3.74159376 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 3.65256353 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 3.61352235 |
| 18 | regulation of protein glycosylation (GO:0060049) | 3.59441231 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 3.58020657 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 3.55687733 |
| 21 | maturation of SSU-rRNA (GO:0030490) | 3.45932873 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.39530648 |
| 23 | protein neddylation (GO:0045116) | 3.33127228 |
| 24 | oxidative phosphorylation (GO:0006119) | 3.31274209 |
| 25 | proteasome assembly (GO:0043248) | 3.27500037 |
| 26 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.27280317 |
| 27 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.22523802 |
| 28 | xenobiotic catabolic process (GO:0042178) | 3.20995365 |
| 29 | tryptophan catabolic process (GO:0006569) | 3.18512643 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 3.18512643 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 3.18512643 |
| 32 | L-serine metabolic process (GO:0006563) | 3.18394586 |
| 33 | respiratory chain complex IV assembly (GO:0008535) | 3.15446963 |
| 34 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.15413233 |
| 35 | bile acid biosynthetic process (GO:0006699) | 3.14749222 |
| 36 | deoxyribose phosphate catabolic process (GO:0046386) | 3.12735324 |
| 37 | autophagic vacuole fusion (GO:0000046) | 3.12323054 |
| 38 | formation of translation preinitiation complex (GO:0001731) | 3.12305780 |
| 39 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.11799051 |
| 40 | cytochrome complex assembly (GO:0017004) | 3.10596888 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09909210 |
| 42 | protein complex biogenesis (GO:0070271) | 3.09844763 |
| 43 | kynurenine metabolic process (GO:0070189) | 3.09577321 |
| 44 | respiratory electron transport chain (GO:0022904) | 3.09227204 |
| 45 | electron transport chain (GO:0022900) | 3.07303017 |
| 46 | lysine metabolic process (GO:0006553) | 3.06690673 |
| 47 | lysine catabolic process (GO:0006554) | 3.06690673 |
| 48 | ATP synthesis coupled proton transport (GO:0015986) | 3.03547483 |
| 49 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.03547483 |
| 50 | deoxyribonucleotide catabolic process (GO:0009264) | 3.02913385 |
| 51 | tryptophan metabolic process (GO:0006568) | 3.02719602 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 3.01768830 |
| 53 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.98449738 |
| 54 | rRNA modification (GO:0000154) | 2.95296194 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 2.93058811 |
| 56 | aromatic amino acid family metabolic process (GO:0009072) | 2.91983269 |
| 57 | cytidine metabolic process (GO:0046087) | 2.91428754 |
| 58 | cytidine catabolic process (GO:0006216) | 2.91428754 |
| 59 | cytidine deamination (GO:0009972) | 2.91428754 |
| 60 | sulfur amino acid biosynthetic process (GO:0000097) | 2.90896404 |
| 61 | purine nucleotide salvage (GO:0032261) | 2.90452691 |
| 62 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.88342885 |
| 63 | L-methionine salvage (GO:0071267) | 2.87046152 |
| 64 | L-methionine biosynthetic process (GO:0071265) | 2.87046152 |
| 65 | amino acid salvage (GO:0043102) | 2.87046152 |
| 66 | nucleoside salvage (GO:0043174) | 2.86963422 |
| 67 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.86781511 |
| 68 | folic acid-containing compound metabolic process (GO:0006760) | 2.86209750 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 2.86143277 |
| 70 | ribosome biogenesis (GO:0042254) | 2.83415349 |
| 71 | organelle membrane fusion (GO:0090174) | 2.82861094 |
| 72 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.82233123 |
| 73 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.82063994 |
| 74 | folic acid transport (GO:0015884) | 2.81959297 |
| 75 | pteridine-containing compound metabolic process (GO:0042558) | 2.81764791 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 2.80877989 |
| 77 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.80836189 |
| 78 | regulation of triglyceride catabolic process (GO:0010896) | 2.80668316 |
| 79 | homocysteine metabolic process (GO:0050667) | 2.79560248 |
| 80 | aldehyde catabolic process (GO:0046185) | 2.78433451 |
| 81 | ribosome assembly (GO:0042255) | 2.78211195 |
| 82 | ribosomal small subunit biogenesis (GO:0042274) | 2.78048737 |
| 83 | tetrahydrofolate metabolic process (GO:0046653) | 2.77939814 |
| 84 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.77534877 |
| 85 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.76026131 |
| 86 | viral transcription (GO:0019083) | 2.75782248 |
| 87 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.75633124 |
| 88 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.75546020 |
| 89 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.74616897 |
| 90 | translational termination (GO:0006415) | 2.74488206 |
| 91 | response to interferon-beta (GO:0035456) | 2.72725635 |
| 92 | GPI anchor biosynthetic process (GO:0006506) | 2.72582531 |
| 93 | ribosomal large subunit biogenesis (GO:0042273) | 2.71933762 |
| 94 | urea cycle (GO:0000050) | 2.71826015 |
| 95 | urea metabolic process (GO:0019627) | 2.71826015 |
| 96 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.71446088 |
| 97 | * pantothenate metabolic process (GO:0015939) | 2.71038088 |
| 98 | deoxyribose phosphate metabolic process (GO:0019692) | 2.70665786 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 2.70523053 |
| 100 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.69893831 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.68140556 |
| 102 | UMP biosynthetic process (GO:0006222) | 2.67231127 |
| 103 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.67231127 |
| 104 | UMP metabolic process (GO:0046049) | 2.67231127 |
| 105 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.67231127 |
| 106 | actin nucleation (GO:0045010) | 2.64900051 |
| 107 | alpha-linolenic acid metabolic process (GO:0036109) | 2.64423811 |
| 108 | sulfur amino acid metabolic process (GO:0000096) | 2.64081444 |
| 109 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.64067304 |
| 110 | translational elongation (GO:0006414) | 2.63474735 |
| 111 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.63416706 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.63236997 |
| 113 | urate metabolic process (GO:0046415) | 2.62938790 |
| 114 | negative regulation of fibrinolysis (GO:0051918) | 2.62909157 |
| 115 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.62418689 |
| 116 | bile acid metabolic process (GO:0008206) | 2.62409783 |
| 117 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.61448703 |
| 118 | imidazole-containing compound metabolic process (GO:0052803) | 2.59511210 |
| 119 | ketone body metabolic process (GO:1902224) | 2.58659482 |
| 120 | cellular glucuronidation (GO:0052695) | 2.58497595 |
| 121 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.57864637 |
| 122 | nitrogen cycle metabolic process (GO:0071941) | 2.57693574 |
| 123 | branched-chain amino acid catabolic process (GO:0009083) | 2.57174465 |
| 124 | protein deneddylation (GO:0000338) | 2.57085698 |
| 125 | valine metabolic process (GO:0006573) | 2.56897269 |
| 126 | B cell mediated immunity (GO:0019724) | 2.56506792 |
| 127 | one-carbon metabolic process (GO:0006730) | 2.56443618 |
| 128 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.55797040 |
| 129 | NADH dehydrogenase complex assembly (GO:0010257) | 2.55797040 |
| 130 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.55797040 |
| 131 | cullin deneddylation (GO:0010388) | 2.55491933 |
| 132 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.55445961 |
| 133 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.55445961 |
| 134 | regulation of mitochondrial translation (GO:0070129) | 2.55436935 |
| 135 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.55330891 |
| 136 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.55330891 |
| 137 | high-density lipoprotein particle remodeling (GO:0034375) | 2.55324183 |
| 138 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.55152178 |
| 139 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.54677326 |
| 140 | platelet dense granule organization (GO:0060155) | 2.54335314 |
| 141 | translational initiation (GO:0006413) | 2.54161907 |
| 142 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.53286029 |
| 143 | methionine metabolic process (GO:0006555) | 2.52180430 |
| 144 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.51833540 |
| 145 | regulation of protein activation cascade (GO:2000257) | 2.51707667 |
| 146 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.51363818 |
| 147 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.51308595 |
| 148 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.51138565 |
| 149 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.51044190 |
| 150 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.51044190 |
| 151 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.50979042 |
| 152 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.50066219 |
| 153 | translation (GO:0006412) | 2.49962875 |
| 154 | proline metabolic process (GO:0006560) | 2.49264212 |
| 155 | branched-chain amino acid metabolic process (GO:0009081) | 2.46274230 |
| 156 | histamine secretion (GO:0001821) | 2.44020458 |
| 157 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.42428983 |
| 158 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.42353747 |
| 159 | neutrophil activation (GO:0042119) | 2.41623275 |
| 160 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.36461109 |
| 161 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.36461109 |
| 162 | daunorubicin metabolic process (GO:0044597) | 2.36415825 |
| 163 | polyketide metabolic process (GO:0030638) | 2.36415825 |
| 164 | doxorubicin metabolic process (GO:0044598) | 2.36415825 |
| 165 | mitochondrial calcium ion transport (GO:0006851) | 2.36197260 |
| 166 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.34489827 |
| 167 | positive regulation of B cell differentiation (GO:0045579) | 2.32858110 |
| 168 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.32786588 |
| 169 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.32786588 |
| 170 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.32786588 |
| 171 | regulation of B cell apoptotic process (GO:0002902) | 2.32134544 |
| 172 | deoxyribonucleotide metabolic process (GO:0009262) | 2.32017619 |
| 173 | GPI anchor metabolic process (GO:0006505) | 2.31734413 |
| 174 | cellular response to interferon-beta (GO:0035458) | 2.31695391 |
| 175 | adenosine metabolic process (GO:0046085) | 2.30927525 |
| 176 | glutathione derivative metabolic process (GO:1901685) | 2.30479092 |
| 177 | glutathione derivative biosynthetic process (GO:1901687) | 2.30479092 |
| 178 | protein maturation by protein folding (GO:0022417) | 2.29799475 |
| 179 | S-adenosylmethionine metabolic process (GO:0046500) | 2.29638160 |
| 180 | nucleotide salvage (GO:0043173) | 2.27727511 |
| 181 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.27009245 |
| 182 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.26953002 |
| 183 | negative regulation of acute inflammatory response (GO:0002674) | 2.25256980 |
| 184 | negative regulation of T cell apoptotic process (GO:0070233) | 2.24408209 |
| 185 | mannosylation (GO:0097502) | 2.23226082 |
| 186 | cellular response to zinc ion (GO:0071294) | 2.22226202 |
| 187 | proton transport (GO:0015992) | 2.20615831 |
| 188 | ubiquinone biosynthetic process (GO:0006744) | 2.20437891 |
| 189 | hydrogen transport (GO:0006818) | 2.20202479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.47268871 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.20404590 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.63847086 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.54836754 |
| 5 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.94494865 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87791486 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.84732188 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.82623599 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.78041824 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.70145643 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.69689431 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67922616 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.59426774 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.57227435 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.56804637 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.52978083 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.51417465 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.49838652 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.49008388 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.48204362 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37092285 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.31204674 |
| 23 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.31044141 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25138367 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.09656222 |
| 26 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.07581172 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.05188537 |
| 28 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.92084959 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.91337134 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.89621871 |
| 31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.87937234 |
| 32 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.86005188 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80979911 |
| 34 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.80891361 |
| 35 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.79312038 |
| 36 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.76514260 |
| 37 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.75108381 |
| 38 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.72595707 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71188787 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.70605818 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.69493371 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.67072915 |
| 43 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66071415 |
| 44 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.64221067 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61328995 |
| 46 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.59163534 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59013996 |
| 48 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.55169378 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.55026122 |
| 50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.52083638 |
| 51 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.52049689 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.51994471 |
| 53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.51133953 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.48947528 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.44263066 |
| 56 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44055080 |
| 57 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42968048 |
| 58 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42729020 |
| 59 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.41783357 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39878854 |
| 61 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36603636 |
| 62 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.36505690 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31715281 |
| 64 | AR_20517297_ChIP-Seq_VCAP_Human | 1.31493606 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31053896 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30057362 |
| 67 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.29717705 |
| 68 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.27555405 |
| 69 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.27037864 |
| 70 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26669043 |
| 71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26196974 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25979381 |
| 73 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.22385335 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.21936718 |
| 75 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.20911344 |
| 76 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.20723363 |
| 77 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20165467 |
| 78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19670247 |
| 79 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17750670 |
| 80 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.16627896 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16443749 |
| 82 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15157988 |
| 83 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.15015149 |
| 84 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14673042 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13682533 |
| 86 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.13446802 |
| 87 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12970769 |
| 88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12715901 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12684401 |
| 90 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12514996 |
| 91 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12514996 |
| 92 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.12313691 |
| 93 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12161045 |
| 94 | MYC_22102868_ChIP-Seq_BL_Human | 1.11869113 |
| 95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.10168892 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09756189 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.09438547 |
| 98 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.08962905 |
| 99 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08585419 |
| 100 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08513296 |
| 101 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.08288238 |
| 102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07709765 |
| 103 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07015028 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05763482 |
| 105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04326333 |
| 106 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03371204 |
| 107 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02527139 |
| 108 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02074501 |
| 109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00895943 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 0.98973838 |
| 111 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98572192 |
| 112 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97526575 |
| 113 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97313144 |
| 114 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.97054652 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97042195 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96320261 |
| 117 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96189683 |
| 118 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94179047 |
| 119 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.93565442 |
| 120 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93537418 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92406123 |
| 122 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.92123925 |
| 123 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91744810 |
| 124 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.91740110 |
| 125 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.91495971 |
| 126 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.90637337 |
| 127 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89540842 |
| 128 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89508287 |
| 129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89490917 |
| 130 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88657911 |
| 131 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88569159 |
| 132 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.88476319 |
| 133 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87951738 |
| 134 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87906988 |
| 135 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87776151 |
| 136 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87270393 |
| 137 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87268143 |
| 138 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86757295 |
| 139 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85708278 |
| 140 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.85269953 |
| 141 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.85197598 |
| 142 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.85168298 |
| 143 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.85073142 |
| 144 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85043361 |
| 145 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.84102524 |
| 146 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.83793064 |
| 147 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.83135037 |
| 148 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.82478389 |
| 149 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.82139029 |
| 150 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82062766 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81303422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.31839457 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.26943741 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 5.09776375 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 5.04171902 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.93083521 |
| 6 | MP0005365_abnormal_bile_salt | 3.80281660 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.33339730 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.93371033 |
| 9 | MP0003724_increased_susceptibility_to | 2.81089979 |
| 10 | MP0009840_abnormal_foam_cell | 2.52055707 |
| 11 | MP0005332_abnormal_amino_acid | 2.49205570 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.44575163 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.35423492 |
| 14 | MP0003186_abnormal_redox_activity | 2.34584065 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.30918686 |
| 16 | MP0003252_abnormal_bile_duct | 2.24306863 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.08371950 |
| 18 | MP0002166_altered_tumor_susceptibility | 1.99954425 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 1.97661737 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.89757288 |
| 21 | MP0010386_abnormal_urinary_bladder | 1.89509425 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.85641992 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.83797975 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.82175817 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.80756188 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.79983178 |
| 27 | MP0001764_abnormal_homeostasis | 1.77688729 |
| 28 | MP0003195_calcinosis | 1.77478251 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.74239245 |
| 30 | MP0003111_abnormal_nucleus_morphology | 1.73503719 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.73013929 |
| 32 | MP0006082_CNS_inflammation | 1.71310077 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.70477312 |
| 34 | MP0002723_abnormal_immune_serum | 1.69038753 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.68054791 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.66168411 |
| 37 | MP0001790_abnormal_immune_system | 1.64528145 |
| 38 | MP0005387_immune_system_phenotype | 1.64528145 |
| 39 | MP0002419_abnormal_innate_immunity | 1.62777905 |
| 40 | MP0005083_abnormal_biliary_tract | 1.62038557 |
| 41 | MP0000609_abnormal_liver_physiology | 1.60583662 |
| 42 | MP0003077_abnormal_cell_cycle | 1.56053925 |
| 43 | MP0008057_abnormal_DNA_replication | 1.55047543 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.50630743 |
| 45 | MP0001819_abnormal_immune_cell | 1.50429666 |
| 46 | MP0002006_tumorigenesis | 1.49920417 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.49537454 |
| 48 | MP0002163_abnormal_gland_morphology | 1.43160466 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.38356693 |
| 50 | MP0003718_maternal_effect | 1.34692423 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.34042578 |
| 52 | MP0000604_amyloidosis | 1.31394225 |
| 53 | MP0000598_abnormal_liver_morphology | 1.27500207 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26761546 |
| 55 | MP0003436_decreased_susceptibility_to | 1.26741436 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 1.23443265 |
| 57 | MP0009764_decreased_sensitivity_to | 1.23057322 |
| 58 | MP0003075_altered_response_to | 1.21550616 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.18738661 |
| 60 | MP0003787_abnormal_imprinting | 1.18562673 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 1.17972979 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 1.17428487 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.17032141 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.16451197 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.16451197 |
| 66 | MP0001853_heart_inflammation | 1.15590780 |
| 67 | MP0008058_abnormal_DNA_repair | 1.15517286 |
| 68 | MP0004147_increased_porphyrin_level | 1.13374706 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.12221385 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.11115370 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 1.11033889 |
| 72 | MP0000716_abnormal_immune_system | 1.09982198 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.08785048 |
| 74 | MP0001730_embryonic_growth_arrest | 1.08348191 |
| 75 | MP0008004_abnormal_stomach_pH | 1.05935343 |
| 76 | MP0005367_renal/urinary_system_phenotyp | 1.04753493 |
| 77 | MP0000516_abnormal_urinary_system | 1.04753493 |
| 78 | MP0001542_abnormal_bone_strength | 1.04242189 |
| 79 | MP0005166_decreased_susceptibility_to | 1.03736957 |
| 80 | MP0000490_abnormal_crypts_of | 1.02858260 |
| 81 | MP0002396_abnormal_hematopoietic_system | 1.02850898 |
| 82 | MP0002405_respiratory_system_inflammati | 1.02807257 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 1.02255005 |
| 84 | MP0000343_altered_response_to | 1.00507238 |
| 85 | MP0008469_abnormal_protein_level | 0.99814277 |
| 86 | MP0009333_abnormal_splenocyte_physiolog | 0.99731886 |
| 87 | MP0005266_abnormal_metabolism | 0.98797022 |
| 88 | MP0009697_abnormal_copulation | 0.98083206 |
| 89 | MP0008932_abnormal_embryonic_tissue | 0.97509484 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.97000206 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91819698 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.91385497 |
| 93 | MP0001533_abnormal_skeleton_physiology | 0.91177594 |
| 94 | MP0008872_abnormal_physiological_respon | 0.88805662 |
| 95 | MP0005410_abnormal_fertilization | 0.88360085 |
| 96 | MP0000689_abnormal_spleen_morphology | 0.88260557 |
| 97 | MP0009785_altered_susceptibility_to | 0.88160878 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.86603591 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.86422478 |
| 100 | MP0005408_hypopigmentation | 0.85640221 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.85389822 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.85361191 |
| 103 | MP0005670_abnormal_white_adipose | 0.85246057 |
| 104 | MP0004043_abnormal_pH_regulation | 0.84468177 |
| 105 | MP0001873_stomach_inflammation | 0.83842521 |
| 106 | MP0005451_abnormal_body_composition | 0.83692484 |
| 107 | MP0005535_abnormal_body_temperature | 0.83205417 |
| 108 | MP0001756_abnormal_urination | 0.82038601 |
| 109 | MP0009642_abnormal_blood_homeostasis | 0.78113546 |
| 110 | MP0003786_premature_aging | 0.77823069 |
| 111 | MP0002722_abnormal_immune_system | 0.77740883 |
| 112 | MP0005671_abnormal_response_to | 0.77610273 |
| 113 | MP0001835_abnormal_antigen_presentation | 0.77544774 |
| 114 | MP0008007_abnormal_cellular_replicative | 0.77536853 |
| 115 | MP0001919_abnormal_reproductive_system | 0.77054052 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.76624406 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.75185004 |
| 118 | MP0009763_increased_sensitivity_to | 0.74865777 |
| 119 | MP0005395_other_phenotype | 0.74311187 |
| 120 | MP0003866_abnormal_defecation | 0.73175480 |
| 121 | MP0005023_abnormal_wound_healing | 0.73105261 |
| 122 | MP0005389_reproductive_system_phenotype | 0.71602991 |
| 123 | MP0000350_abnormal_cell_proliferation | 0.70592602 |
| 124 | MP0000477_abnormal_intestine_morphology | 0.70238320 |
| 125 | MP0000685_abnormal_immune_system | 0.68081594 |
| 126 | MP0004947_skin_inflammation | 0.67446566 |
| 127 | MP0005380_embryogenesis_phenotype | 0.66707402 |
| 128 | MP0001672_abnormal_embryogenesis/_devel | 0.66707402 |
| 129 | MP0002132_abnormal_respiratory_system | 0.66404247 |
| 130 | MP0002080_prenatal_lethality | 0.65953910 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.64629124 |
| 132 | MP0003984_embryonic_growth_retardation | 0.64301227 |
| 133 | MP0008873_increased_physiological_sensi | 0.64181374 |
| 134 | MP0010155_abnormal_intestine_physiology | 0.63859248 |
| 135 | MP0001243_abnormal_dermal_layer | 0.63249795 |
| 136 | MP0002088_abnormal_embryonic_growth/wei | 0.63129272 |
| 137 | MP0005025_abnormal_response_to | 0.60836566 |
| 138 | MP0002398_abnormal_bone_marrow | 0.60831894 |
| 139 | MP0001697_abnormal_embryo_size | 0.60616675 |
| 140 | MP0009672_abnormal_birth_weight | 0.60432490 |
| 141 | MP0002429_abnormal_blood_cell | 0.59858733 |
| 142 | MP0000358_abnormal_cell_content/ | 0.59429647 |
| 143 | MP0003868_abnormal_feces_composition | 0.59248524 |
| 144 | MP0001800_abnormal_humoral_immune | 0.58619794 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.58229605 |
| 146 | MP0002086_abnormal_extraembryonic_tissu | 0.58117515 |
| 147 | MP0003123_paternal_imprinting | 0.57858682 |
| 148 | MP0003011_delayed_dark_adaptation | 0.56641744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.15304432 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.66157858 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 4.41638308 |
| 4 | Hyperglycinuria (HP:0003108) | 4.26728596 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.25577012 |
| 6 | Hyperglycinemia (HP:0002154) | 3.97927173 |
| 7 | Hyperammonemia (HP:0001987) | 3.76966776 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 3.66486177 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.66486177 |
| 10 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.63738994 |
| 11 | Xanthomatosis (HP:0000991) | 3.38091151 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 3.28289170 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27783485 |
| 14 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.25043944 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.21398021 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.19862255 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.19373891 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.19249241 |
| 19 | Generalized aminoaciduria (HP:0002909) | 3.10901907 |
| 20 | Lethargy (HP:0001254) | 3.10373702 |
| 21 | Progressive macrocephaly (HP:0004481) | 3.09188572 |
| 22 | Dicarboxylic aciduria (HP:0003215) | 3.08462701 |
| 23 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.08462701 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.02300180 |
| 25 | Cerebral edema (HP:0002181) | 3.01683720 |
| 26 | Hepatic necrosis (HP:0002605) | 3.01588690 |
| 27 | Oral leukoplakia (HP:0002745) | 3.00236629 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98170668 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 2.97546278 |
| 30 | Hypolipoproteinemia (HP:0010981) | 2.92981332 |
| 31 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.85798096 |
| 32 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.85798096 |
| 33 | Increased intramyocellular lipid droplets (HP:0012240) | 2.85446943 |
| 34 | Gout (HP:0001997) | 2.85210648 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 2.84643713 |
| 36 | Abnormality of serum amino acid levels (HP:0003112) | 2.79540330 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 2.73840436 |
| 38 | Ketosis (HP:0001946) | 2.69980618 |
| 39 | Abnormality of the prostate (HP:0008775) | 2.69375654 |
| 40 | Renal Fanconi syndrome (HP:0001994) | 2.66405894 |
| 41 | Delayed CNS myelination (HP:0002188) | 2.65900907 |
| 42 | Type I transferrin isoform profile (HP:0003642) | 2.63076115 |
| 43 | Hyperlipoproteinemia (HP:0010980) | 2.61340932 |
| 44 | Fat malabsorption (HP:0002630) | 2.60693095 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.60512798 |
| 46 | Acute encephalopathy (HP:0006846) | 2.57913805 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.55616214 |
| 48 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.53932249 |
| 49 | Nausea (HP:0002018) | 2.53092780 |
| 50 | Multiple enchondromatosis (HP:0005701) | 2.52673085 |
| 51 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.50849224 |
| 52 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.50849224 |
| 53 | Abnormal protein glycosylation (HP:0012346) | 2.50849224 |
| 54 | Abnormal glycosylation (HP:0012345) | 2.50849224 |
| 55 | Hepatocellular necrosis (HP:0001404) | 2.48409106 |
| 56 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.45914199 |
| 57 | Abnormal number of erythroid precursors (HP:0012131) | 2.44248931 |
| 58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.43669454 |
| 59 | Petechiae (HP:0000967) | 2.41818682 |
| 60 | Megaloblastic anemia (HP:0001889) | 2.41673533 |
| 61 | Stomatitis (HP:0010280) | 2.41456828 |
| 62 | Reticulocytopenia (HP:0001896) | 2.40330344 |
| 63 | Colon cancer (HP:0003003) | 2.38179748 |
| 64 | Metaphyseal dysplasia (HP:0100255) | 2.37938096 |
| 65 | Proximal tubulopathy (HP:0000114) | 2.36811530 |
| 66 | Increased serum lactate (HP:0002151) | 2.36544289 |
| 67 | Macrocytic anemia (HP:0001972) | 2.33589445 |
| 68 | Birth length less than 3rd percentile (HP:0003561) | 2.32475826 |
| 69 | Metabolic acidosis (HP:0001942) | 2.32027623 |
| 70 | Abnormality of the intrinsic pathway (HP:0010989) | 2.30852541 |
| 71 | Lactic acidosis (HP:0003128) | 2.29342673 |
| 72 | Cerebral palsy (HP:0100021) | 2.26574827 |
| 73 | Hyperbilirubinemia (HP:0002904) | 2.26528574 |
| 74 | Renal cortical cysts (HP:0000803) | 2.26017817 |
| 75 | Respiratory failure (HP:0002878) | 2.24551439 |
| 76 | Breast hypoplasia (HP:0003187) | 2.24246055 |
| 77 | Carpal bone hypoplasia (HP:0001498) | 2.23955887 |
| 78 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.23764171 |
| 79 | Increased CSF lactate (HP:0002490) | 2.23151355 |
| 80 | Exertional dyspnea (HP:0002875) | 2.22036783 |
| 81 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.21658115 |
| 82 | Severe combined immunodeficiency (HP:0004430) | 2.19985022 |
| 83 | Increased serum pyruvate (HP:0003542) | 2.19642303 |
| 84 | Abnormality of glycolysis (HP:0004366) | 2.19642303 |
| 85 | Autoimmune hemolytic anemia (HP:0001890) | 2.17880892 |
| 86 | Abnormality of the common coagulation pathway (HP:0010990) | 2.17694577 |
| 87 | Rough bone trabeculation (HP:0100670) | 2.16971790 |
| 88 | Aplastic anemia (HP:0001915) | 2.15874213 |
| 89 | CNS demyelination (HP:0007305) | 2.15491339 |
| 90 | Abnormality of urine glucose concentration (HP:0011016) | 2.15199944 |
| 91 | Glycosuria (HP:0003076) | 2.15199944 |
| 92 | 3-Methylglutaconic aciduria (HP:0003535) | 2.14957749 |
| 93 | Acute necrotizing encephalopathy (HP:0006965) | 2.14757403 |
| 94 | Palpitations (HP:0001962) | 2.13509179 |
| 95 | Late onset (HP:0003584) | 2.12824558 |
| 96 | Abnormality of B cell number (HP:0010975) | 2.12549391 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.11963001 |
| 98 | Recurrent abscess formation (HP:0002722) | 2.11827441 |
| 99 | Irritability (HP:0000737) | 2.11810548 |
| 100 | Ragged-red muscle fibers (HP:0003200) | 2.11417807 |
| 101 | Complement deficiency (HP:0004431) | 2.10957207 |
| 102 | Abnormality of purine metabolism (HP:0004352) | 2.08899701 |
| 103 | Hypoalphalipoproteinemia (HP:0003233) | 2.08231749 |
| 104 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08187380 |
| 105 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08187380 |
| 106 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08187380 |
| 107 | Steatorrhea (HP:0002570) | 2.05914947 |
| 108 | Vomiting (HP:0002013) | 2.04264622 |
| 109 | Mitochondrial inheritance (HP:0001427) | 2.03981776 |
| 110 | Malnutrition (HP:0004395) | 2.01421757 |
| 111 | Abnormality of macrophages (HP:0004311) | 2.00219910 |
| 112 | IgG deficiency (HP:0004315) | 1.99683967 |
| 113 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99673929 |
| 114 | Obstructive lung disease (HP:0006536) | 1.99673929 |
| 115 | Thrombocytosis (HP:0001894) | 1.97768693 |
| 116 | Thyroiditis (HP:0100646) | 1.97449407 |
| 117 | Abnormality of renal resorption (HP:0011038) | 1.96268622 |
| 118 | Joint hemorrhage (HP:0005261) | 1.94898508 |
| 119 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94582202 |
| 120 | Recurrent bacterial skin infections (HP:0005406) | 1.94506400 |
| 121 | Ketoacidosis (HP:0001993) | 1.93640431 |
| 122 | B lymphocytopenia (HP:0010976) | 1.93396341 |
| 123 | Exercise intolerance (HP:0003546) | 1.92369751 |
| 124 | Rhabdomyolysis (HP:0003201) | 1.92229129 |
| 125 | Pili torti (HP:0003777) | 1.91917248 |
| 126 | Reduced antithrombin III activity (HP:0001976) | 1.91711195 |
| 127 | Methylmalonic aciduria (HP:0012120) | 1.90853535 |
| 128 | Increased muscle lipid content (HP:0009058) | 1.90645166 |
| 129 | Epidermoid cyst (HP:0200040) | 1.89764913 |
| 130 | Abnormal cartilage morphology (HP:0002763) | 1.88678038 |
| 131 | Increased purine levels (HP:0004368) | 1.86179682 |
| 132 | Hyperuricemia (HP:0002149) | 1.86179682 |
| 133 | Abolished electroretinogram (ERG) (HP:0000550) | 1.85453293 |
| 134 | Methylmalonic acidemia (HP:0002912) | 1.85262493 |
| 135 | Chronic diarrhea (HP:0002028) | 1.85189648 |
| 136 | Joint swelling (HP:0001386) | 1.83859376 |
| 137 | Optic disc pallor (HP:0000543) | 1.83615580 |
| 138 | Progressive neurologic deterioration (HP:0002344) | 1.83428092 |
| 139 | Abnormality of alanine metabolism (HP:0010916) | 1.83223717 |
| 140 | Hyperalaninemia (HP:0003348) | 1.83223717 |
| 141 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83223717 |
| 142 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.83123874 |
| 143 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.81375004 |
| 144 | Villous atrophy (HP:0011473) | 1.81375004 |
| 145 | Neonatal onset (HP:0003623) | 1.79650349 |
| 146 | Eczematoid dermatitis (HP:0000976) | 1.79207393 |
| 147 | Posterior subcapsular cataract (HP:0007787) | 1.79012558 |
| 148 | Pancreatitis (HP:0001733) | 1.77526957 |
| 149 | Spastic diplegia (HP:0001264) | 1.77461510 |
| 150 | Sparse eyelashes (HP:0000653) | 1.77176307 |
| 151 | Abnormality of the anterior horn cell (HP:0006802) | 1.76525028 |
| 152 | Degeneration of anterior horn cells (HP:0002398) | 1.76525028 |
| 153 | Increased cerebral lipofuscin (HP:0011813) | 1.76334837 |
| 154 | Increased IgM level (HP:0003496) | 1.75847510 |
| 155 | Hyperphosphaturia (HP:0003109) | 1.74946349 |
| 156 | Microcytic anemia (HP:0001935) | 1.74605773 |
| 157 | Death in infancy (HP:0001522) | 1.74073266 |
| 158 | Hypoproteinemia (HP:0003075) | 1.73796044 |
| 159 | Medial flaring of the eyebrow (HP:0010747) | 1.71404019 |
| 160 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.70277709 |
| 161 | Abnormal spermatogenesis (HP:0008669) | 1.69949811 |
| 162 | Hepatosplenomegaly (HP:0001433) | 1.68726151 |
| 163 | Abnormality of the basal ganglia (HP:0002134) | 1.68416192 |
| 164 | Granulocytopenia (HP:0001913) | 1.68321403 |
| 165 | Eosinophilia (HP:0001880) | 1.67611793 |
| 166 | Skin rash (HP:0000988) | 1.67005623 |
| 167 | Respiratory difficulties (HP:0002880) | 1.66302352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.36947836 |
| 2 | BCKDK | 4.07066818 |
| 3 | MAP3K12 | 3.40748569 |
| 4 | WEE1 | 3.25233878 |
| 5 | STK16 | 3.20899145 |
| 6 | TESK2 | 3.20774046 |
| 7 | NME2 | 3.10048143 |
| 8 | EIF2AK1 | 3.05625264 |
| 9 | PIK3CA | 2.34537993 |
| 10 | RIPK1 | 2.30677784 |
| 11 | SCYL2 | 2.22192323 |
| 12 | VRK2 | 2.16534444 |
| 13 | TRIM28 | 2.06128865 |
| 14 | MAP3K11 | 2.05617064 |
| 15 | TAOK3 | 1.97275002 |
| 16 | MAP4K2 | 1.94034204 |
| 17 | EIF2AK3 | 1.83237935 |
| 18 | MAP2K3 | 1.81214677 |
| 19 | KDR | 1.80238872 |
| 20 | EPHA2 | 1.79230754 |
| 21 | NUAK1 | 1.74130197 |
| 22 | ZAK | 1.67549357 |
| 23 | MAP4K1 | 1.66399203 |
| 24 | FLT3 | 1.63646002 |
| 25 | STK10 | 1.53995247 |
| 26 | TLK1 | 1.51404070 |
| 27 | PLK4 | 1.50000143 |
| 28 | MAP3K3 | 1.48252856 |
| 29 | MAP2K2 | 1.47543667 |
| 30 | ERN1 | 1.46553322 |
| 31 | FGFR4 | 1.45530425 |
| 32 | RPS6KB2 | 1.43845244 |
| 33 | BRSK2 | 1.43780127 |
| 34 | CSF1R | 1.42353651 |
| 35 | BMPR1B | 1.42085511 |
| 36 | TAOK2 | 1.39969965 |
| 37 | MAPKAPK3 | 1.39699524 |
| 38 | FRK | 1.37870419 |
| 39 | NEK1 | 1.35583358 |
| 40 | ARAF | 1.35485087 |
| 41 | BMPR2 | 1.34868100 |
| 42 | VRK1 | 1.31166021 |
| 43 | ZAP70 | 1.24730282 |
| 44 | DYRK3 | 1.24336558 |
| 45 | GRK6 | 1.21520948 |
| 46 | TTK | 1.21275806 |
| 47 | NLK | 1.20277653 |
| 48 | MAP3K8 | 1.19680866 |
| 49 | RPS6KA4 | 1.18492845 |
| 50 | CDC7 | 1.17273479 |
| 51 | GRK1 | 1.17089474 |
| 52 | TESK1 | 1.16494463 |
| 53 | LMTK2 | 1.16397063 |
| 54 | PIM2 | 1.14149428 |
| 55 | SIK3 | 1.13983606 |
| 56 | ITK | 1.13381345 |
| 57 | SYK | 1.13298895 |
| 58 | NEK2 | 1.11139508 |
| 59 | PLK1 | 1.11012521 |
| 60 | FES | 1.09391120 |
| 61 | AURKB | 1.08131621 |
| 62 | RIPK4 | 1.06765068 |
| 63 | PRKCQ | 1.05608505 |
| 64 | ERBB3 | 1.04451839 |
| 65 | DAPK1 | 1.02396442 |
| 66 | ADRBK2 | 1.01922915 |
| 67 | TNK2 | 0.98811255 |
| 68 | AURKA | 0.95905912 |
| 69 | PRKCI | 0.95203881 |
| 70 | IRAK3 | 0.94417077 |
| 71 | MAP3K14 | 0.93262132 |
| 72 | SRPK1 | 0.92847042 |
| 73 | WNK3 | 0.92390729 |
| 74 | PIM1 | 0.90510586 |
| 75 | PIK3CG | 0.89866562 |
| 76 | CDK7 | 0.88455618 |
| 77 | TSSK6 | 0.87776440 |
| 78 | PASK | 0.84304888 |
| 79 | OXSR1 | 0.82953831 |
| 80 | STK24 | 0.82822740 |
| 81 | TYK2 | 0.82376780 |
| 82 | CDK4 | 0.82198531 |
| 83 | ILK | 0.82188502 |
| 84 | MAP3K13 | 0.81730198 |
| 85 | STK39 | 0.81430514 |
| 86 | BCR | 0.80628756 |
| 87 | PDK3 | 0.78778795 |
| 88 | PDK4 | 0.78778795 |
| 89 | DAPK3 | 0.78742151 |
| 90 | BLK | 0.78123911 |
| 91 | ACVR1B | 0.77079077 |
| 92 | TBK1 | 0.75490030 |
| 93 | WNK4 | 0.74556284 |
| 94 | MYLK | 0.73843215 |
| 95 | PLK3 | 0.69437465 |
| 96 | CHEK2 | 0.67316160 |
| 97 | LRRK2 | 0.66827961 |
| 98 | AKT3 | 0.65934459 |
| 99 | MARK3 | 0.65626087 |
| 100 | MAPK11 | 0.64901832 |
| 101 | MST4 | 0.64349200 |
| 102 | ABL2 | 0.64284255 |
| 103 | LCK | 0.64162390 |
| 104 | BRSK1 | 0.63457305 |
| 105 | NME1 | 0.61815224 |
| 106 | CSK | 0.61656945 |
| 107 | FER | 0.61191363 |
| 108 | CSNK1G3 | 0.60597380 |
| 109 | MUSK | 0.60576857 |
| 110 | PAK4 | 0.59990659 |
| 111 | TXK | 0.59933806 |
| 112 | EIF2AK2 | 0.58335329 |
| 113 | CSNK2A2 | 0.58033897 |
| 114 | TAOK1 | 0.57551055 |
| 115 | ATR | 0.57313390 |
| 116 | MAP3K5 | 0.53769160 |
| 117 | MAP2K7 | 0.53728730 |
| 118 | LIMK1 | 0.52909032 |
| 119 | CSNK2A1 | 0.52775115 |
| 120 | KIT | 0.51134406 |
| 121 | IKBKB | 0.51110662 |
| 122 | STK4 | 0.50757857 |
| 123 | TEC | 0.49649134 |
| 124 | BRAF | 0.48736098 |
| 125 | PKN2 | 0.45993305 |
| 126 | PRKCE | 0.45711458 |
| 127 | MAP2K6 | 0.45705691 |
| 128 | CDK19 | 0.45264805 |
| 129 | MELK | 0.44362881 |
| 130 | MATK | 0.44326190 |
| 131 | ABL1 | 0.43999961 |
| 132 | PDK2 | 0.43570718 |
| 133 | IKBKE | 0.42678301 |
| 134 | JAK3 | 0.40220792 |
| 135 | BTK | 0.40076385 |
| 136 | PRKCD | 0.39634025 |
| 137 | PINK1 | 0.39013311 |
| 138 | CSNK1G2 | 0.38950068 |
| 139 | RPS6KA5 | 0.38485789 |
| 140 | IGF1R | 0.38470799 |
| 141 | CHUK | 0.38332802 |
| 142 | PRKG2 | 0.37791908 |
| 143 | CAMKK2 | 0.37429510 |
| 144 | PBK | 0.37235745 |
| 145 | DYRK2 | 0.37009605 |
| 146 | LYN | 0.36503386 |
| 147 | CHEK1 | 0.35174154 |
| 148 | HCK | 0.34747805 |
| 149 | ERBB4 | 0.34434149 |
| 150 | MAP3K10 | 0.34237970 |
| 151 | PTK2 | 0.33426691 |
| 152 | DAPK2 | 0.33173846 |
| 153 | STK38L | 0.32833139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 2.74189516 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.73140245 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.56311462 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45359774 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.43498419 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40897312 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.35032189 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.34328621 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28174782 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.21724624 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17691502 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.12717525 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.07933393 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.07410212 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.06383046 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.96424354 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.90993880 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.86429044 |
| 19 | * Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.86033785 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.84582556 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83943785 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.79988644 |
| 23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.77774203 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.77644495 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.76233598 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.75695883 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.72471756 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.71897673 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.68612343 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.65941188 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.63833477 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.61586626 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.61338787 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59684122 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.59628599 |
| 36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.56255258 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.54444486 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52341612 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49228577 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41487004 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.41290292 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40731517 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40370114 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.39028209 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38522228 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37274714 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 1.37185145 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34601163 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28423758 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26835667 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23653312 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22911063 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.22890094 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21503717 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.20840312 |
| 56 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.20242170 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.17898504 |
| 58 | RNA transport_Homo sapiens_hsa03013 | 1.17594330 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16666151 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 1.15223540 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13212179 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13049510 |
| 63 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10924631 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09193114 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 1.08238196 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.07078674 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06841902 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05324085 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03715001 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02297154 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00190011 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99007554 |
| 73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.98900446 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97363585 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97101651 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96035196 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95996269 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94761715 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94476499 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93681217 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | 0.91975314 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91408085 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.91108582 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89208935 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89163621 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88859284 |
| 87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.87796969 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86891545 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84886114 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82151737 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.81749256 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80094796 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79767371 |
| 94 | Protein export_Homo sapiens_hsa03060 | 0.78872266 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78729260 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76851913 |
| 97 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.76097648 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75952022 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75161177 |
| 100 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75110493 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74670865 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72589973 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72029386 |
| 104 | Cell cycle_Homo sapiens_hsa04110 | 0.70844988 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70474081 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63895504 |
| 107 | Purine metabolism_Homo sapiens_hsa00230 | 0.61905094 |
| 108 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61555550 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.59443913 |
| 110 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58679731 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56648578 |
| 112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53759967 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53127307 |
| 114 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49450357 |
| 115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48797374 |
| 116 | Tuberculosis_Homo sapiens_hsa05152 | 0.48636951 |
| 117 | RNA degradation_Homo sapiens_hsa03018 | 0.47798899 |
| 118 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45645114 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45070761 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.45024452 |
| 121 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41500567 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41109258 |
| 123 | Legionellosis_Homo sapiens_hsa05134 | 0.40459518 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38303696 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38231714 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36884155 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34992807 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.34678346 |
| 129 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32548341 |
| 130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.28906061 |
| 131 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28402824 |
| 132 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.27269050 |

